Voya Investment Management LLC Vertex Pharmaceuticals Inc Transaction History

Voya Investment Management LLC

$86.1 Billion
Q1 2024

A detailed history of Voya Investment Management LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Voya Investment Management LLC holds 939,426 shares of VRTX stock, worth $445 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares

939,426

Previous 775,488 21.14%

Holding current value

$445 Million

Previous $316 Million 24.45%

% of portfolio

0.46%

Previous 0.39%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$407.69 - $446.08 $66.8 Million - $73.1 Million	163,938 Added 21.14%	939,426 $393 Million
Q4 2023 Feb 14, 2024	SELL	$343.0 - $410.68 $28.7 Million - $34.3 Million	-83,547 Reduced 9.73%	775,488 $316 Million
Q3 2023 Nov 14, 2023	BUY	$338.18 - $362.46 $10.8 Million - $11.6 Million	32,080 Added 3.88%	859,035 $299 Million
Q2 2023 Aug 14, 2023	SELL	$314.42 - $351.91 $25.9 Million - $29 Million	-82,280 Reduced 9.05%	826,955 $291 Million
Q1 2023 May 15, 2023	SELL	$283.23 - $323.1 $81 Million - $92.4 Million	-285,922 Reduced 23.92%	909,235 $286 Million

Q4 2022 Feb 14, 2023	BUY	$285.76 - $321.48 $70.4 Million - $79.2 Million	246,336 Added 25.96%	1,195,157 $345 Million
Q3 2022 Mar 03, 2023	SELL	$273.83 - $305.53 $67.5 Million - $75.3 Million	-246,336 Reduced 20.61%	948,821 $275 Million
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $191 Million - $213 Million	698,774 Added 279.46%	948,821 $275 Million
Q2 2022 Aug 15, 2022	BUY	$234.96 - $292.55 $32.3 Million - $40.3 Million	137,679 Added 122.53%	250,047 $70.5 Million
Q1 2022 May 16, 2022	SELL	$221.42 - $260.97 $770,320 - $907,914	-3,479 Reduced 3.0%	112,368 $29.3 Million
Q4 2021 Feb 14, 2022	SELL	$177.01 - $223.45 $2.33 Million - $2.94 Million	-13,143 Reduced 10.19%	115,847 $25.4 Million
Q3 2021 Nov 15, 2021	SELL	$181.39 - $202.99 $1.14 Million - $1.28 Million	-6,293 Reduced 4.65%	128,990 $23.4 Million
Q2 2021 Aug 16, 2021	SELL	$187.49 - $221.1 $2.69 Million - $3.17 Million	-14,344 Reduced 9.59%	135,283 $27.3 Million
Q1 2021 May 17, 2021	SELL	$207.02 - $241.31 $1.89 Million - $2.2 Million	-9,136 Reduced 5.75%	149,627 $32.2 Million
Q4 2020 Feb 16, 2021	SELL	$207.01 - $276.09 $136 Million - $181 Million	-654,859 Reduced 80.49%	158,763 $37.5 Million
Q3 2020 Nov 16, 2020	SELL	$255.65 - $303.1 $9.69 Million - $11.5 Million	-37,913 Reduced 4.45%	813,622 $221 Million
Q2 2020 Aug 14, 2020	SELL	$225.48 - $295.8 $39.2 Million - $51.4 Million	-173,885 Reduced 16.96%	851,535 $247 Million
Q1 2020 May 15, 2020	SELL	$199.77 - $247.81 $5.67 Million - $7.04 Million	-28,399 Reduced 2.69%	1,025,420 $244 Million
Q4 2019 Feb 14, 2020	BUY	$166.71 - $223.91 $960,916 - $1.29 Million	5,764 Added 0.55%	1,053,819 $231 Million
Q3 2019 Nov 14, 2019	SELL	$166.23 - $187.09 $4.97 Million - $5.6 Million	-29,920 Reduced 2.78%	1,048,055 $178 Million
Q2 2019 Aug 14, 2019	SELL	$164.61 - $190.37 $4.26 Million - $4.92 Million	-25,854 Reduced 2.34%	1,077,975 $198 Million
Q1 2019 May 15, 2019	SELL	$163.73 - $194.7 $2.12 Million - $2.52 Million	-12,949 Reduced 1.16%	1,103,829 $203 Million
Q4 2018 Feb 14, 2019	SELL	$151.91 - $192.21 $43.6 Million - $55.1 Million	-286,756 Reduced 20.43%	1,116,778 $185 Million
Q3 2018 Nov 14, 2018	BUY	$167.73 - $192.74 $6.77 Million - $7.78 Million	40,376 Added 2.96%	1,403,534 $271 Million
Q2 2018 Aug 14, 2018	BUY	$145.72 - $169.96 $35.4 Million - $41.3 Million	243,077 Added 21.7%	1,363,158 $232 Million
Q1 2018 May 15, 2018	BUY	$151.6 - $177.13 $156 Million - $182 Million	1,026,874 Added 1101.71%	1,120,081 $183 Million
Q4 2017 Feb 14, 2018	SELL	$137.28 - $155.55 $520,428 - $589,690	-3,791 Reduced 3.91%	93,207 $14 Million
Q3 2017 Nov 14, 2017	BUY	$148.13 - $162.24 $14.4 Million - $15.7 Million	96,998	96,998 $14.7 Million

Others Institutions Holding VRTX

# of Institutions

1,623

Shares Held

222M

Call Options Held

1.35M

Put Options Held

1.49M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $122B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.

Account

Voya Investment Management LLC Vertex Pharmaceuticals Inc Transaction History